Status:
UNKNOWN
The Effect of S-ketamine Combined With Sufentanil for Postoperative Analgesia in Patients Following Cesarean Section
Lead Sponsor:
Ling Dong
Conditions:
S-ketamine
Analgesia, Patient-Controlled
Eligibility:
FEMALE
20-40 years
Phase:
PHASE4
Brief Summary
This randomized controlled trial is designed to investigate the effect of low-dose of S-ketamine combined with sufentanil for postoperative patient-controlled intravenous analgesia in patients followi...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists (ASA) physical status II
- Patients aged between 20 and 40 years
- 18 kg/m² ≤BMI≤30 kg/m²
- singleton term pregnancy
- scheduled for elective cesarean section
Exclusion
- Refused to participant in this trial
- Severe heart dysfunction or pulmonary insufficiency
- Poor blood pressure control in those with hypertension (BP \>160/100 mmHg in the ward)
- Previous history of Intracranial hypertension or hyperthyroidism
- Previous history of schizophrenia, epilepsy, myasthenia gravis or delirium
- Allergy to drugs used in the study
Key Trial Info
Start Date :
April 12 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
216 Patients enrolled
Trial Details
Trial ID
NCT05299866
Start Date
April 12 2022
End Date
June 30 2024
Last Update
February 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University
Jinan, Shandong, China, 250000